biblio
“Synthesis and antimicrobial evaluation of novel 2'-aryl-4-aryl-2,4'-Bisthiazole and 2'-aryl-4-Pyridyl-2,4'-bisthiazole derivatives as potential antibacterial agents”, Polycyclic Aromatic Compound , vol. 44, no. 2, pp. 773-787, 2024.
, “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
, “Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis”, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.
, “Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes”, International Journal of Biological Macromolecules, vol. 248, p. 125847, 2023.
, “Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity”, Organic & Biomolecular Chemistry, vol. 21, no. 28, pp. 5725-5731, 2023.
, “Amide-linked monocarbonyl curcumin analogues: efficient synthesis, antitubercular activity and molecular docking study”, Polycyclic Aromatic Compounds, vol. 45, no. 5, pp. 2655-2671, 2022.
, “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
, “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
, “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
, “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
, “Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay”, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.
, “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
, “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
, “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
, “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
, “2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis”, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.
, “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
, “In vitro antitubercular screening and in silico study of germacradienolide from blainvillea latifolia”, Asian Journal of Chemistry, vol. 33, no. 12, pp. 3129-3133, 2021.
, “Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis”, Scientific Reports, vol. 11, no. 1, p. 19813, 2021.
, “Online tools and antiviral databases for the development of drugs against coronaviruses”, in In Silico Modeling of Drugs Against Coronaviruses: Computational Tools and Protocols, New York, NY: Springer US, 2021, pp. 717–734.
, “Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis”, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines (vol 27, pg 979, 2017)”, Bioorganic & Medicinal Chemistry Letters, vol. 32, p. 127737, 2021.
, “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
, “Anticancer potential of AgNPs synthesized using acinetobacter sp. and curcuma aromatica against HeLa cell lines: a comparative study”, Journal of Trace Elements in Medicine and Biology, vol. 62, p. 126630, 2020.
, “Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013”, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.
, “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
, “Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents”, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.
, “Design and synthesis of 2-amino-thiophene-proline-conjugates and their anti-tubercular activity against mycobacterium tuberculosis H37Ra”, ChemistrySelect, vol. 4, no. 9, pp. 2851-2857, 2019.
, “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
, “Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance”, Scientific Reports, vol. 9, p. 9261, 2019.
, “High content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis”, Journal of Microbiological Methods, vol. 164, 2019.
, “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
, “Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives”, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.
, “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
, “Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis”, European Journal of Medicinal Chemistry, vol. 178, pp. 315-328, 2019.
, “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
, “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
, “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
, “Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis”, Plos One, vol. 14, no. 8, p. e0220628, 2019.
, “Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life”, European Journal of Medicinal Chemistry, vol. 152, pp. 358-369, 2018.
, “Conformational studies of Ant-Pro motif-incorporated cyclic peptides: gramicidin S and avellanin”, New Journal of Chemistry, vol. 42, no. 2, pp. 1197-1201, 2018.
, “Design and synthesis of 2-amino-thiophene-tethered ureidopenicillin analogs with potentantibacterial and antitubercular activity”, ChemistrySelect, vol. 3, no. 11, pp. 3122-3126, 2018.
, “Design, synthesis and biological screening of novel 1,3,4-oxadiazoles as antitubercular agents”, Chemistryselect, vol. 3, no. 47, pp. 13304-13310, 2018.
, “Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents”, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.
, “Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors”, European Journal of Medicinal Chemistry, vol. 157, pp. 310-319, 2018.
, “Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against mycobacterium tuberculosis”, RSC Advances, vol. 8, no. 19, pp. 10634-10643, 2018.
, “Novel benzylidenehydrazide-1,2,3-triazole conjugates as antitubercular agents: synthesis and molecular docking”, Mini Reviews in Medicinal Chemistry, vol. 18, 2018.
, “Novel red fluorescence protein based microplate assay for drug screening against dormant mycobacterium tuberculosis by using paraffin”, Tuberculosis, vol. 110, pp. 15-19, 2018.
, “ Rational design of coumarin derivatives as antituberculosis agents”, Future Medicinal Chemistry, vol. 10, no. 20, pp. 2431-2444, 2018.
, “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
, “Synthesis and biological evaluation of some bicyclic [2-(2,4-dimethylphenylthio)phenyl] aniline and its amide derivatives as potential antitubercular agents”, Journal of Chemical Sciences, vol. 130, no. 3, p. 22, 2018.
, “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.
, “Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars”, Synthetic Communications, vol. 48, no. 5, pp. 524-540, 2018.
, “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
, “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
, “Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa”, Plos One, vol. 12 , no. 4, p. e0174241, 2017.
, “Carboxymethyl cellulose-grafted mesoporous silica hybrid nanogels for enhanced cellular uptake and release of curcumin”, Gels, vol. 3, no. 1, 2017.
, “Click-chemistry-based multicomponent condensation approach for design and synthesis of spirochromene-tethered 1,2,3-triazoles as potential antitubercular agents”, Research on Chemical Intermediates, vol. 43, no. 10, pp. 5675-5690, 2017.
, “Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies”, European Journal of Medicinal Chemistry, vol. 127, 2017.
, “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
, “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
, “New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 2, pp. 288–294, 2017.
, “Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: synthesis and molecular docking study”, Bioorganic & medicinal chemistry letters, vol. 27, no. 4, pp. 922-928, 2017.
, “Quinolidene-rhodanine conjugates: facile synthesis and biological evaluation”, European Journal of Medicinal Chemistry, vol. 125, pp. 385–399, 2017.
, “Superoxide generation and its involvement in the growth of mycobacterium smegmatis”, Frontiers in Microbiology, vol. 8, p. Article Number: 105, 2017.
, “Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives”, European Journal of Medicinal Chemistry, vol. 132, pp. 333-340, 2017.
, “Synthesis and antitubercular activity of new thiazolidinones with pyrazinyl and thiazolyl scaffolds”, Journal of Heterocyclic Chemistry, vol. 54, no. 1, pp. 125-130, 2017.
, “Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as anti-mycobacterial agents”, Chemical Biology & Drug Design, vol. 90, no. 2, pp. 200-209, 2017.
, “Synthesis and biological evaluation of new fluconazole β-lactam conjugates linked via 1,2,3-triazole”, New Journal of Chemistry, vol. 41, no. 2, pp. 470-479, 2017.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocycl- yl-2,6-dicyanoanilines”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 4, pp. 979-988, 2017.
, “Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives”, Medicinal Chemistry Research, 2017.
, “Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis”, Chemical Biology & Drug Design, vol. 90, no. 6, pp. 1206-1214, 2017.
, “Synthesis of novel triazole-incorporated isatin derivatives as antifungal, antitubercular, and antioxidant agents and molecular docking study”, Journal of Heterocyclic Chemistry, vol. 54, no. 413, 2017.
, “Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents”, European Journal of Medicinal Chemistry, vol. 122, pp. 475-487, 2016.
, “[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity”, Research on Chemical Intermediates, vol. 42, no. 8, pp. 6607-6626, 2016.
, “Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1704-1708, 2016.
, “Graphene quantum dots - from emergence to nanotheranostic applications”, in Smart Drug Delivery System, Croatia: Intech, 2016.
, “GSH Induced controlled release of levofloxacin from a purpose-built prodrug: luminescence response for probing the drug release in escherichia coli and staphylococcus aureus”, Bioconjugate Chemistry, vol. 27, no. 9, pp. 2062-2070, 2016.
, “In vitro and ex vivo antitubercular activity of diarylheptanoids from the rhizomes of alpinia officinarum hance”, Natural Product Research, vol. 30, no. 24, pp. 2825-2830, 2016.
, “Isolates of alpinia officinarum hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies”, International Immunopharmacology, vol. 33, pp. 8-17, 2016.
, “Naturally occurring anti-TB agents: isolation, chemical transformations and in vitro antitubercular activities of secondary metabolites of rhizomes of alpinia galanga”, Planta Medica International Open, vol. 3, no. 3, pp. e55-e59, 2016.
, “New dinor-cis-labdane diterpene and flavonoids with antimycobacterium activity from colebrookea oppositifolia”, Planta Medica Letters, vol. 3, no. 1, pp. e20-e24, 2016.
, “New pimarane diterpenes and other antimycobacterial metabolites from anisochilus verticillatus”, Natural Product Research, vol. 30, no. 6, pp. 675-681, 2016.
, “Novel tetrazoloquinoline-rhodanine conjugates: highly efficient synthesis and biological evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2278-2283, 2016.
, “Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking”, Medchemcomm, vol. 7, no. 9, pp. 1832-1848, 2016.
, “Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents”, International Journal of Nanomedicine, vol. 11, p. 1889—1897, 2016.
, “Shape and size engineered cellulosic nanomaterials as broad spectrum anti-microbial compounds”, International Journal of Biological Macromolecules, vol. 87, pp. 460-465, 2016.
, “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
, “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
, “Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.
, “Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.
, “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents (vol 6, pg 2209, 2015)”, Medchemcomm, vol. 7, no. 2, p. 379, 2016.
, “Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives”, Bioorganic Chemistry, vol. 64, pp. 97-102, 2016.
, “Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.
, “Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents”, Research on Chemical Intermediates, vol. 42, no. 3, pp. 2707-2729, 2016.
, “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
, “Two chitotriose-specific lectins show anti-angiogenesis, induces caspase-9-mediated apoptosis and early arrest of pancreatic tumor cell cycle”, Plos One, vol. 11, no. 1, p. Article Number: e0146110, 2016.
, “1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study”, MedChemComm, vol. 6, no. 6, pp. 1104-1116, 2015.
, “Analyzing different acetyl co-a metabolizing enzymes as potential drug targets against mycobacterium tuberculosis”, British Microbiology Research Journal, vol. 10, no. 4, pp. 1-15, 2015.
,